Abstract:Drug discovery typically consists of multiple steps, including identifying a target protein key to a disease's etiology, validating that interacting with this target could prevent symptoms or cure the disease, discovering a small molecule or biologic therapeutic to interact with it, and optimizing the candidate molecule through a complex landscape of required properties. Drug discovery related tasks often involve prediction and generation while considering multiple entities that potentially interact, which poses a challenge for typical AI models. For this purpose we present MAMMAL - Molecular Aligned Multi-Modal Architecture and Language - a method that we applied to create a versatile multi-task multi-align foundation model that learns from large-scale biological datasets (2 billion samples) across diverse modalities, including proteins, small molecules, and genes. We introduce a prompt syntax that supports a wide range of classification, regression, and generation tasks. It allows combining different modalities and entity types as inputs and/or outputs. Our model handles combinations of tokens and scalars and enables the generation of small molecules and proteins, property prediction, and transcriptomic lab test predictions. We evaluated the model on 11 diverse downstream tasks spanning different steps within a typical drug discovery pipeline, where it reaches new SOTA in 9 tasks and is comparable to SOTA in 2 tasks. This performance is achieved while using a unified architecture serving all tasks, in contrast to the original SOTA performance achieved using tailored architectures. The model code and pretrained weights are publicly available at <a class="link-external link-https" href="https://github.com/BiomedSciAI/biomed-multi-alignment" rel="external noopener nofollow">this https URL</a> and <a class="link-external link-https" href="https://huggingface.co/ibm/biomed.omics.bl.sm.ma-ted-458m" rel="external noopener nofollow">this https URL</a>.

Overlay databank unlocks data-driven analyses of biomolecules for all

Overlay databank unlocks data-driven analyses of biomolecules for all

Biomolecular NMR spectroscopy in the era of artificial intelligence

MISATO - Machine Learning Dataset for Structure-Based Drug Discovery

A sandbox for prediction and integration of DNA, RNA, and proteins in single cells

MDRepo - an open environment for data warehousing and knowledge discovery from molecular dynamics simulations

InstructBioMol: Advancing Biomolecule Understanding and Design Following Human Instructions

Integrated Database of Force-Field Parameters, Experimental Measurements and Molecular Dynamics Simulations

A cloud platform for automating and sharing analysis of raw simulation data from high throughput polymer molecular dynamics simulations

Perspective: on the importance of extensive, high-quality and reliable deposition of biomolecular NMR data in the age of artificial intelligence

The need to implement FAIR principles in biomolecular simulations

Comprehensive Lipidomic Automation Workflow using Large Language Models

Application of Deep Learning for Studying NMDA Receptors

ANI-1: A data set of 20M off-equilibrium DFT calculations for organic molecules

Research and development of MolAICal for drug design via deep learning and classical programming

MolData, a molecular benchmark for disease and target based machine learning

Enabling Open Machine Learning of DNA Encoded Library Selections to Accelerate the Discovery of Small Molecule Protein Binders

MAMMAL -- Molecular Aligned Multi-Modal Architecture and Language

Identifying protein conformational states in the Protein Data Bank: Toward unlocking the potential of integrative dynamics studies

AMPL: A Data-Driven Modeling Pipeline for Drug Discovery

HTMoL: full-stack solution for remote access, visualization, and analysis of Molecular Dynamics trajectory data